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Purpose: The present study aimed to evaluate the frequency and risk factors of retinopathy of prematurity
(ROP) among Iranian infants.
Methods: A retrospective cohort study was conducted on infants who had undergone screening for ROP
at Farabi Eye Hospital, between March 2016 and March 2017. Data were analyzed based on the presence
of extreme prematurity (gestational age ≤ 28 weeks), extremely low-birth-weight (≤ 1000 g), and multiple-
gestation (MG) infants.
Results: The prevalence of ROP was 27.28% (𝑛 = 543) among all screened infants, 74.4% for extremely
preterm (EP) infants, 77.5% for extremely low birth weight (ELBW) babies, and 27.25% for infants from MG
pregnancies. On multivariate analysis, gestational age, birth weight, and history of transfusion (𝑃 < 0.0001,
𝑃 < 0.0001, and 𝑃 = 0.04, respectively) were found to be significantly associated with ROP. More advanced
stages of ROP (𝑃 < 0.0001) were observed in EP and ELBW infants. Birth weight (𝑃 = 0.088), history of
transfusion (𝑃 = 0.066), and intubation (𝑃 = 0.053) were not associated with increased risk of ROP in EP
infants, while gestational age (𝑃 = 0.037) and history of transfusion (𝑃 = 0.040) were significant risk factors
for ROP in ELBW infants. Gestational age (P < 0.001) and birth weight (𝑃 = 0.001) were significantly associated
with ROP in infants from MG pregnancies in multivariate analysis.
Conclusion: ROP remains a commonly encountered disease, especially in ELBW and EP infants. The history
of transfusion may have a role in stratifying the risk for ROP and guiding future screening guidelines.
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INTRODUCTION
Retinopathy of prematurity (ROP) is the leading
cause of visual impairment in premature infants
and is characterized by abnormal peripheral retinal
vascularization.[1] The incidence of ROP is influ-
enced by several factors including gestational age,
birth weight, genetics, ethnicity, and level of neona-
tal care. Gestational age is defined as the length of
time of growth of the fetus in the uterus. Screening
programs should be regionally tailored to account
for these differences. Advances in prenatal and
neonatal care have resulted in increasing rates of
ROP in the developing world.[2–4]
Gestational age and birth weight are the two
most well-established risk factors for ROP, with
other factors such as oxygen therapy, history of
transfusion, sepsis, and anemia being less signif-
icantly associated with ROP.[5] ROP is diagnosed
only in a minority of premature infants, with a
smaller subset requiring intervention. As a result,
better understanding of risk factors of progression
to ROP, especially in those cases requiring treat-
ment, would allow for more effective screening
programs.[5, 6]
The purpose of this study is to evaluate the
prevalence of ROP and associated risk factors in a
tertiary eye center in Tehran. Additional subgroup
analysis was done for patients in three high risk
categories: extremely low birth weight (≤ 1,000 g,
ELBW), extremely preterm (≤ 28 weeks, EP), and
multiple gestational (MG) infants.
METHODS
The current retrospective cohort study was per-
formed at Farabi Eye Hospital from March 2016
until March 2017 after obtaining approval from
the Institutional Review Board (IRB) of Tehran
University of Medical Sciences. The tenets of the
Declaration of Helsinki were followed. The medical
records of all patients referred to the ROP clinic
were assessed. All infants with gestational age ≤
37 weeks were included in this study. Patients with
incomplete medical records were excluded from
the analysis. Demographic data (gestational age,
birth weight, and gender) and ophthalmic findings
(ROP stage, zone, and laterality) were collected and
categorized for each patient. Stages of ROP were
diagnosed based on the international classification
of ROP as follows:
Stage 0: immature retinal vasculature without
pathologic changes
Stage 1: presence of a demarcation line between
the vascularized and non-vascularized retina
Stage 2: presence of a demarcation line that has
height, width, and volume (ridge); small, isolated
tufts of neovascular tissue lying on the surface of
the retina, commonly known as, “popcorn” may be
present.
Stage 3: a ridge with extraretinal fibrovascular
proliferation that may be mild, moderate, or severe,
as judged by the amount of proliferative tissue
present.
Stage 4: partial retinal detachment (A)
Extrafoveal retinal detachment; (B) Retinal
detachment involving the fovea
Stage 5: total retinal detachment with funnel
configuration
Threshold is defined as retinal neovasculariza-
tion with an extension of either a continuous five
clock hour or eight cumulative clock hours in zone
I or II with plus disease.
Pre-threshold disease is characterized by all
zone I and II changes, except zone II stage 1 and
zone II stage 2 without plus disease that do not
include the criteria of threshold disease, and is
divided into two types:
Type 1:
Zone I, any stage ROP with plus disease,
Zone I, stage 3 ROP without plus disease, or
Zone III, stage 2 or 3 ROP with plus disease
Type 2:
Zone I, stage 1 or 2 ROPwithout plus disease and
Zone II, stage 3 ROP without plus disease
For the purpose of analysis, the stage of ROP
in patients with bilateral disease was categorized
based on the eye with the highest stage and
lowest zone. Additionally, the history of sepsis,
transfusion, acute respiratory distress syndrome
(ARDS), oxygen therapy, intubation, intraventric-
ular hemorrhage (IVH), and phototherapy were
analyzed as risk factors for ROP. Follow-up visits,
indications for treatment, types of treatment, and
final ROP status at the last examination were also
collected for each patient.
Data was analyzed using IBM SPSS version 19
(Armonk, NY: IBM Corp). Mean ± standard devi-
ation was used to report data. After confirmation
292 J  O  V R Volume 14, Issue 3, July–September 2019
Review of 1,990 Cases of ROP; Zarei et al
of the normal distribution of data by Shapiro-
Wilk test, the comparison between birth weight
and gestational age of patients with and without
ROPwas performed using student 𝑡-test. Univariate
logistic regression was performed to determine the
significance of different potential predictive risk
factors (gestational age, birth weight, transfusion,
sepsis, ARDS, oxygen therapy, intubation, IVH,
and phototherapy) in the development of ROP
(dependent variable). Subsequently, the resultant
significant risk factors were evaluated using multi-
variate logistic regression to discern the confound-
ing factors. 𝑃 -value < 0.05 in the 𝑡-test and logistic
regression was considered statistically significant.
RESULTS
Subjects
A total of 1,990 patients met the inclusion criteria.
Mean gestational age was 32.29 ± 2.75 weeks
(range: 24 ± 37 weeks) and mean birth weight was
1,757.99 ± 563.51 g. The cohort comprised of 51.5%
(1024) male infants.
Retinopathy of Prematurity
The prevalence of ROP was 27.28% (𝑛 = 543).
Four hundred and sixty-eight patients (23.52%)
had bilateral disease and 75 (3.76%) cases had
unilateral disease (23 right eyes and 52 left eyes).
Stage of ROP is outlined in Table 1. The mean
number of examinations and the mean time to the
first examination was 2.4 ± 2.6 (1–36) and 7.6 ±
9.1 weeks, respectively. Cases of ROP diagnosed
at initial visit were as follows: Pre-threshold 1
(57 patients, 2.9% of the total number of cases),
threshold (77 patients, 3.9%), stage 4a (15 patients,
0.75%), stage 5 (26 patients, 1.3%), regressed ROP
with unfavorable outcome (3 patients, 0.15%), and
other forms of ROP (pre-threshold 2 and less
severe) (365 patients, 18.3%). Thirty-two patients
were diagnosed with ROP during follow-up visits.
Risk Factors
Univariate andmultivariate logistic regression anal-
yses were performed to examine the relationship
between the different risk factors and development
of ROP. Gestational age, birth weight, transfusion,
ARDS, oxygen therapy, sepsis, intubation, and IVH
were significant risk factors on univariate analysis;
however, only gestational age, birth weight, and
transfusion remained significant on multivariate
analysis. [Tables 2 and 3]. Gestational age (𝑃 =
0.010), birth weight (𝑃 < 0.0001), and IVH (𝑃 = 0.028)
were significant risk factors for ROP that required
treatment.
Treatment
One hundred and eighty patients underwent treat-
ment, which included intravitreal injection of beva-
cizumab [IVB, (155 eyes, 86% of patients)], laser
(98 eyes, 54%), scleral buckle (5 eyes, 0.05%),
vitrectomy (7 eyes, 4%), combination of IVB and
scleral buckle (2 eyes, 1%), and combination of IVB
and vitrectomy (1 eye, 0.5%). Twenty-nine patients
(47 eyes) required retreatment, including 18 eyes
with laser (previous treatment included IVB in
16 eyes and laser in 2 eyes), 17 eyes with IVB
(previous treatment included IVB in all), 8 eyes with
vitrectomy (previous treatment included laser in 4
eyes and IVB in 4 eyes), and 4 eyes with scleral
buckle (previous treatment included laser in 2 eyes
and IVB in 2 eyes). Seven eyes required a third
treatment: vitrectomy in five eyes (all were primarily
treated with IVB, followed by laser), and sclera
buckle in two eyes (both received IVB followed by
vitrectomy).
Extremely Preterm Patients
Two hundred and twenty-three patients were born
EP. Mean gestational age and birth weight were
27.24 ± 0.96 weeks and 1,086.50 ± 268.41 g,
respectively. Multi-gestation births (56 patients,
25%), transfusion (142 patients, 63.7%), intubation
(34 patients, 15.2%), sepsis (102 patients, 46%),
ARDS (176 patients, 79%), oxygen therapy (159
patients, 71%, data of oxygen therapy in 34 patients
with ARDS were not documented in the archived
files), phototherapy (159 patients, 71%), and IVH
(20 patients, 9%) were frequently encountered.
One hundred and sixty-six (74.4%) EP patients
developed ROP: pre-threshold ROP in 32 patients
(14%), threshold ROP in 45 patients (20%), stage
4a in 8 patients (3.6%), stage 5 in 12 patients
(5.3%), other stages in 68 patients, and unfavorable
structural outcome in 1 patient (0.4%). Stage of
ROP was more advanced in EP infants than non-EP
infants (chi-square test, 𝑃 < 0.001).
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Table 1. The rate and stage of ROP in infants with gestational age equal or less than 37 weeks
ROP Right Eye Left Eye
Frequency (%) Frequency (%)
No ROP 914 (45.9) 904 (45.4)
Immature retina (avascular area) 585 (29.4) 566 (28.4)
Prethreshold Type 2 and less severe forms of ROP 322 (16.2) 349 (17.5)
Pre-threshold ROP Type 1 60 (3) 56 (2.8)
Threshold ROP 75 (3.8) 76 (3.8)
Stage 4a 11 (0.6) 14 (0.7)
Stage 5 21 (1.1) 22 (1.1)
Autoregressed ROP with unfavorable outcome 2 (0.1) 3 (0.2)
ROP, retinopathy of prematurity
Table 2. Data of univariate regression analysis of different risk factors in the development of retinopathy of prematurity
With ROP (n = 575) Without ROP (n = 1415) Significance Odds Ratio 95% CI
Gestational age 29.98 ± 2.38 33.34 ± 2.50 < 0.001 0.594 0.565–0.620
Birth weight 1,364.95 ± 417.21 1,936 ± 555.64 < 0.001 0.998 0.997–0.998
Gender (female/male) 292/283 674/741 0.211 0.882 0.724–1.074
Multiple gestations (MGs) 183 458 0.908 0.988 0.799–1.280
Oxygen therapy 379 835 < 0.001 3.320 2.347–4.697
Transfusion 229 190 < 0.001 4.269 3.347–5.444
Intra ventricular
hemorrhage
31 27 < 0.001 3.035 1.788–5.149
Sepsis 223 422 0.005 1.358 1.097–1.680
ARDS 391 742 < 0.001 3.320 2.347–4.697
Phototherapy 343 826 0.736 0.955 0.729–1.250
Intubation 58 77 < 0.001 2.146 1.493–3.084
ARDS, acute respiratory distress syndrome; CI, confidence interval; ROP, retinopathy of prematurity
Fifty-seven (25%) EP patients did not develop
ROP (no ROP in 20 patients and immature retina
in 37 patients). Birth weight, transfusion, and intu-
bation were not significant (although with a trend
toward significance) risk factors for ROP in EP
infants on multivariate analysis (𝑃 = 0.088, 0.066,
and 0.053, respectively).
Extremely Low Birth Weight Infants
One hundred and sixty patients had ELBW. Trans-
fusion (97 patients, 61%), intubation (25 patients,
15.6%), sepsis (66 patients, 41%), ARDS (123
patients, 77%), oxygen therapy (123 patients, 77%),
phototherapy (99 patients, 62%), and IVH (14
patients, 8.7%) were commonly observed. One
hundred and twenty-four (77.5%) patients were
affected by ROP: 24 (15%) patients with Type 1
pre-threshold ROP, 31 (19%) with threshold ROP,
5 (3%) with stage 4a, 10 (6%) with stage 5, and
54 (33.8%) patients with other stages. Thirty-six
patients (22.5%) did not develop ROP (no ROP in
12 patients and immature retina in 24 patients). In
multivariate analysis, gestational age (𝑃 = 0.037)
and transfusion (𝑃 = 0.040) were found to be
significantly associated with the development of
ROP.
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Table 3. Data of multivariate regression analysis of different risk factors in the development of retinopathy of prematurity
Wald Significance Odds Ratio 95% CI
Gestational age 64.002 < 0.001 0.724 0.668–0.783
Birth weight 19.313 < 0.001 0.999 0.999–0.999
Gender 0.807 0.369 0.873 0.650–1.174
Multiple gestations .011 0.915 1.017 0.747–1.385
Oxygen therapy 0.463 0.496 1.253 0.655–2.397
Transfusion 3.869 0.049 1.355 1.001–1.833
Intra ventricular hemorrhage 2.094 0.148 1.728 0.824–3.624
Sepsis 1.252 0.263 1.172 0.888–1.547
ARDS 1.686 0.194 1.401 0.842–2.333
Phototherapy 0.125 0.724 0.937 0.652–1.345
Intubation 1.480 0.224 1.349 0.833–2.184
ARDS, acute respiratory distress syndrome; CI, confidence interval
Multiple Gestations
Six hundred and forty-two babies belonged to MG
pregnancies including twins (511 cases, 79.6%),
triplets (115 cases, 18%), quadruplets (9 cases, 1.4%),
quintuplets (5 cases, 0.8%), and sextuplets (1 case,
0.15%). Themean gestational agewas 32.36±2.56
weeks and birth weight was 1,692.94 ± 457.12 g.
Transfusion (130 patients, 20%), intubation
(39 patients, 6%), sepsis (216 patients, 33.7%),
ARDS (369 patients, 57.4%), oxygen therapy (393
patients, 61.2%), phototherapy (399 patients, 62%),
and IVH (16 patients, 2.5%) were encountered.
One hundred and seventy-five patients (27.2%)
developed ROP: Type 1 pre-threshold ROP in
14 patients (2.2%), threshold ROP in 29 patients
(4.5%), stage 4a in 7 patients (1%), stage 5 in 5
patients (0.7%), and other stages in 120 patients
(18.7%). Four hundred and sixty-seven patients
(72.7%) did not develop ROP, of which 181 (28%)
had immature retinas. On multivariate analysis,
gestational age and birth weight were shown to
be significant risk factors associated with ROP (𝑃
< 0.001 and 0.001, respectively). Fifty-eight babies
(9%) were treated for ROP. Severity of ROP and
the rate of treated cases were similar between MG
and single gestation babies.
DISCUSSION
In this series, the rate of ROP was 27.28% on
initial evaluation, with 1.6% developing ROP on
subsequent follow-up. The rate of ROP reported in
the literature ranges from 11.4 to 44% due to the
differences in economic status, ethnicity, genetics,
practice setting, screening programs, and level of
perinatal care at the respective institutions.[6–14] A
previous report from Iran found an 8.5% prevalence
of ROP among premature infants.[15] The increased
rate observed in the current study may be due
to improved perinatal care, which has resulted
in longer survival of high-risk infants. There is a
considerable debate regarding the risk factors for
ROP. In the present cohort, low gestational age and
birth weight, history of transfusion, ARDS, oxygen
therapy, sepsis, intubation, and IVH were signif-
icant risk factors for ROP on univariate analysis;
however, on multivariate analysis only gestational
age, birth weight, and history of transfusion were
found to be statistically significant. Gestational age,
birth weight, and IVH were significantly associated
with the treatment for ROP among all infants on
multivariate analysis (𝑃 = 0.010, < 0.001 and 0.028,
respectively). Table 4 provides a summary of the
rates of ROP and risk factors across several studies.
Multiple studies have identified lower gestational
age and birth weight, higher number of days
of oxygen therapy, mechanical ventilation, hyper-
glycemia, sepsis, transfusion, inadequate weight
gain during the first two weeks, and IVH as risk
factors for ROP, with low gestational age and birth
weight being the most consistently demonstrated
risk factors.[6, 8, 11, 12, 16–18] Khalesi et al.[19] observed
gestational age, apnea score in the first minute,
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Table 4. The rate of development of ROP and significant risk factors in some studies
Study Sample size Rate of ROP Risk factors
Liu et al[13] 1,846 12.8% Birth weight, gestational age, days of oxygen
supplementation, and myocardial injury after birth
Chen et al[12] 472 12.7% Gestational age, birth weight, preeclampsia, and maternal
oxygen supplement before or at the time of delivery
Port et al[6] 1,354 38.8% Birth weight, gestational age, bronchopulmonary dysplasia,
multiple gestation (MG), necrotizing enterocolitis, race and
ethnicity
Mohamed et al[17] 582 29% Univariate analysis: birth weight, gestational age, patent
ductus arteriosus, sepsis, intraventricular hemorrhage (IVH),
lung disease, days of hyperglycemia, and prescription of
postnatal steroids Multivariate analysis: gestational age, days
of hyperglycemia, and days of mechanical ventilation
Bossi et al[9] 639 11.4% Univariate analysis: extent of O2-exposure, elevated paCO2,
elevated paO2, paCO2-fluctuations, transfusions, acidosis,
and artificial ventilation Multivariate analysis: acidosis, birth
weight, artificial ventilation, multiple birth, and hours of Fio2
greater than 0.4
Mutlu et al[18] 318 37.1% Gestational age ≤ 32 weeks, birth weight ≤ 1250 g, oxygen
therapy, and sepsis
Kim et al[19] 211 42% Poor weight gain during the first two weeks
This study 1,990 28.9% Univariate analysis: gestational age, birth weight, transfusion,
ARDS, oxygen therapy, sepsis, intubation, and intraventricular
hemorrhage (IVH) Multivariate analysis: gestational age, birth
weight, and history of transfusion
ARDS, acute respiratory distress syndrome; ROP, retinopathy of prematurity
oxygen therapy, and phototherapy as significant
risk factors, whereas Dai et al.[5] suggested that
maternal iron deficiency may be another significant
risk factor in the development of ROP. Increased
oxygen demand during sepsis as well as toxic
effects of high oxygen production during trans-
fusion might result in increased susceptibility to
ROP.[20]
Similarly, Yau et al.[21] observed that the inci-
dence of ROP in patients with a mean gestational
age of 26.4 weeks was 60.7%. Lower birth weight,
transfusion, and intubation approached statistical
significance as risk factors for ROP in the present
cohort of EP patients (𝑃 = 0.088, 0.066 and 0.053,
respectively). Yau et al[21] retrospectively reviewed
EP infants and reported that low gestational age,
lighter birth weight, invasive ventilation were sig-
nificant risk factors for the development of ROP on
univariate analysis.
ROP was common in patients with ELBW (77.5%,
𝑛 = 124), which is consistent with the findings
reported by Celebi et al (75.5%).[25] A wide spec-
trum exists in studies examining the rate of occur-
rence of ROP (32.8 ± 82.5%) and the rate of treat-
ment for ROP (12.7± 48.9%) in ELBW infants.[4, 22–24]
In multivariate analysis, we observed that lower
gestational age (𝑃 = 0.037) and history of transfu-
sion (𝑃 = 0.040) were significant risk factors for the
development of ROP in ELBW infants. Celebi et al
reported that gestational age, birth weight, history
of transfusion, and sepsis were significant factors
associated with severe ROP requiring treatment in
all infants, while only gestational age was statis-
tically significantly associated with ROP requiring
treatment in ELBW infants.[25]
Among patients born of MG pregnancies, lower
gestational age and birth weight were significant
risk factors for ROP (𝑃 < 0.001 and 0.001, respec-
tively), and no significant difference existed in the
severity of ROP and rate of treatment between
MG patients and those born of a single gestation.
Twin-twin transfusion syndrome has been found to
increase the risk for ROP compared to MG alone
(𝑃 < 0.01).[26] Yau et al[27] assessed the risk of
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development of Type 1 ROP in MG infants. MG was
found to be a significant risk factor using univariate
analysis but not in multivariate analysis. Azad et
al[28] observed an increased severity of ROP in
heavier MG babies and concluded that weight
alone cannot be considered a predictive factor for
the severity of ROP. Data from the current study
support the view that MG is not a risk factor for the
development or severity of ROP.
The current series presents a contemporary
analysis of the rate of ROP and risk factors from
a large tertiary center in Iran. The strengths of
this study include the large sample size and
diverse patient population; however, given the
retrospective design, confounding and missing
data were innate limitations in the analysis of
risk factors for ROP. ROP remains a commonly
encountered disease with approximately a quarter
of preterm infants and three-quarters ELBW or EP
infants being affected. Low birth weight and low
gestational age are two essential risk factors for
the development of ROP. In both developed and
developing countries, low gestational age and low
birth weight are the commonly reported risk factors
for ROP; however, other factors appear to play a
larger role in developing countries. On multivariate
analysis, transfusion was a significant risk factor
for ROP in ELBW infants and approached statistical
significance in EP infants. With improvement in
perinatal care in developing countries, the burden
of ROP is likely to increase. As a result, a better
understanding of the patients at risk for ROP,
especially among higher risk sub-groups is critical.
Future studies should focus on creating models
based on multiple risk factors to stratify the risk of
ROP and potentially creating more individualized
screening guidelines.
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